Cancer Suits Over Novartis Eczema Drug Remanded

Law360, New York (June 17, 2009, 12:00 AM EDT) -- A judge has remanded four cases alleging Novartis Pharmaceutical Corp.'s prescription eczema drug Elidel caused them to develop cancer, saying punitive damage claims aren't enough to keep a case in federal court.

In an order Monday, Judge Renee Marie Bumb of the U.S. District Court for the District of New Jersey remanded the cases filed by Salvatore D'Anna, John W. Cummings, Dana Simi-Wilson and Joanne Kelley-Hodges to the Superior Court of New Jersey, Atlantic County.

The suits, which are four among about 35 such lawsuits across...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.